In an effort to simplify the science behind our ambition to ‘drug the undruggable’, this podcast draws back the curtain on cancer research and takes a look at its complex inner workings. Hosted by Sebastian Hermelin (co-founder of the War On Cancer app), each episode welcomes a new expert guest who takes the listener through one of the many stages of cancer research and drug development; from early discovery efforts, through to clinical trials and drug approval.
All content for Taking Cancer On is the property of Boehringer Ingelheim and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In an effort to simplify the science behind our ambition to ‘drug the undruggable’, this podcast draws back the curtain on cancer research and takes a look at its complex inner workings. Hosted by Sebastian Hermelin (co-founder of the War On Cancer app), each episode welcomes a new expert guest who takes the listener through one of the many stages of cancer research and drug development; from early discovery efforts, through to clinical trials and drug approval.
Expert Guests: Keith Perry, lung cancer survivor
In episode 5, we turn our attention to living with lung cancer. Sebastian speaks to Keith Perry, a lung cancer survivor who took a truly awe-inspiring approach to his recovery journey after losing his left lung to cancer.
Disclaimer: This episode reflects the unique experiences of an individual living with lung cancer. The experiences of other people living with lung cancer will vary.
You can subscribe to the series on Apple Podcast, Spotify or Deezer to stay up to date on Taking Cancer On.
Taking Cancer On
In an effort to simplify the science behind our ambition to ‘drug the undruggable’, this podcast draws back the curtain on cancer research and takes a look at its complex inner workings. Hosted by Sebastian Hermelin (co-founder of the War On Cancer app), each episode welcomes a new expert guest who takes the listener through one of the many stages of cancer research and drug development; from early discovery efforts, through to clinical trials and drug approval.
